HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral‐treated HIV /hepatitis C virus‐coinfected patients
Investigating what level of HIV viraemia affects fibrosis progression
View PublicationFilter By:
High Level Antibody Avidity is Achieved in HIV-Seropositive Recipients of an Inactivated Split Adjuvanted (AS03A) Influenza Vaccine
Measuring antibody avidity after influenza vaccination in HIV patients to assess vaccine efficacy
View PublicationCorrelates of drug use cessation among participants in the Canadian HIV–HCV Co-infection Cohort
Examining the occurrence and correlates of drug use cessation among HIV–HCV co-infected drug users participating in HIV care
View PublicationOptimal timing of influenza vaccination in patients with human immunodeficiency virus: A Markov cohort model based on serial study participant hemoagglutination inhibition titers
Investigating the optimal time to administer seasonal influenza vaccination
View PublicationHIV Testing and Counselling in Colombia: Local Experience on Two Different Recruitment Strategies to Better Reach Low Socioeconomic Status Communities
Galindo-Quintero J, Mueses-Marin HF, Montaño-Agudelo D, Pinzón-Fernández MV, Tello-Bolívar IC, Alvarado-Llano BE, Martinez-Cajas JL
Micronutrient Deficiency and Treatment Adherence in a Randomized Controlled Trial of Micronutrient Supplementation in ART-Naïve Persons with HIV
Determining the baseline prevalence of serum micronutrient deficiencies and correlates, as well as tolerance and adherence to study interventions
View PublicationSignificant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history
This study compares HIV treatment outcomes and survival between HIV-HCV coinfected individuals with and without IDU history
View PublicationGender Differences in Clinical Outcomes among HIV-Positive Individuals on Antiretroviral Therapy in Canada: A Multisite Cohort Study
This study investigates gender differences by injection drug use history in virologic responses to ART and mortality
View PublicationFactors Associated with Late Initiation of Highly Active Antiretroviral Therapy among Young HIV-Positive Men and Women Aged 18 to 29 Years in Canada
Examining factors associated with late HAART initiation among 18- to 29-year-olds
View PublicationImpact of Autologous Dendritic Cell–Based Immunotherapy (AGS-004) on B- and T-Cell Subset Changes and Immune Activation in HIV-Infected Patients Receiving Antiretroviral Therapy
Evaluating the modifications in B- and T-cell subsets and the level of immune activation
View Publication